These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19146417)

  • 21. Discovery of a potent and selective GPR120 agonist.
    Shimpukade B; Hudson BD; Hovgaard CK; Milligan G; Ulven T
    J Med Chem; 2012 May; 55(9):4511-5. PubMed ID: 22519963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of biphenyl piperazines as novel and long acting muscarinic acetylcholine receptor antagonists.
    Jin J; Budzik B; Wang Y; Shi D; Wang F; Xie H; Wan Z; Zhu C; Foley JJ; Webb EF; Berlanga M; Burman M; Sarau HM; Morrow DM; Moore ML; Rivero RA; Palovich M; Salmon M; Belmonte KE; Lainé DI
    J Med Chem; 2008 Oct; 51(19):5915-8. PubMed ID: 18798607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A unified synthetic approach to the pyrazinone dragmacidins.
    Garg NK; Stoltz BM
    Chem Commun (Camb); 2006 Sep; (36):3769-79. PubMed ID: 16969454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of orally bioavailable and novel urea agonists of the high affinity niacin receptor GPR109A.
    Shen HC; Szymonifka MJ; Kharbanda D; Deng Q; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Ren N; Cai TQ; Taggart AK; Wang J; Tong X; Waters MG; Hammond ML; Tata JR; Colletti SL
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6723-8. PubMed ID: 18029181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery and optimization of (R)-prolinol-derived agonists of the Growth Hormone Secretagogue receptor (GHSR).
    Zhai W; Flynn N; Longhi DA; Tino JA; Murphy BJ; Slusarchyk D; Gordon DA; Pendri A; Shi S; Stoffel R; Ma B; Sofia MJ; Gerritz SW
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5083-6. PubMed ID: 18722770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemogenomics: structuring the drug discovery process to gene families.
    Harris CJ; Stevens AP
    Drug Discov Today; 2006 Oct; 11(19-20):880-8. PubMed ID: 16997137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of potent and selective GPR119 agonists for type II diabetes.
    Szewczyk JW; Acton J; Adams AD; Chicchi G; Freeman S; Howard AD; Huang Y; Li C; Meinke PT; Mosely R; Murphy E; Samuel R; Santini C; Yang M; Zhang Y; Zhao K; Wood HB
    Bioorg Med Chem Lett; 2011 May; 21(9):2665-9. PubMed ID: 21273063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of small molecule agonists of the thrombopoietin (Tpo) receptor derived from a benzo[a]carbazole hit scaffold.
    Marsilje TH; Alper PB; Lu W; Mutnick D; Michellys PY; He Y; Karanewsky DS; Chow D; Gerken A; Lao J; Kim MJ; Seidel HM; Tian SS
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5259-62. PubMed ID: 18783949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A solid-phase approach to DDB derivatives.
    Qi X; Wang X; Wang L; Wang Q; Cheng S; Suo J; Chang J
    Eur J Med Chem; 2005 Aug; 40(8):805-10. PubMed ID: 16023768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119.
    Semple G; Fioravanti B; Pereira G; Calderon I; Uy J; Choi K; Xiong Y; Ren A; Morgan M; Dave V; Thomsen W; Unett DJ; Xing C; Bossie S; Carroll C; Chu ZL; Grottick AJ; Hauser EK; Leonard J; Jones RM
    J Med Chem; 2008 Sep; 51(17):5172-5. PubMed ID: 18698756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel and potent small-molecule urotensin II receptor agonists.
    Lehmann F; Currier EA; Clemons B; Hansen LK; Olsson R; Hacksell U; Luthman K
    Bioorg Med Chem; 2009 Jul; 17(13):4657-65. PubMed ID: 19481466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists.
    Troxler T; Hurth K; Mattes H; Prashad M; Schoeffter P; Langenegger D; Enz A; Hoyer D
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1305-9. PubMed ID: 19208473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formal concept analysis for the identification of molecular fragment combinations specific for active and highly potent compounds.
    Lounkine E; Auer J; Bajorath J
    J Med Chem; 2008 Sep; 51(17):5342-8. PubMed ID: 18698757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biphenyl versus phenylpyridazine derivatives: the role of the heterocycle in a series of acyl-CoA:cholesterol acyl transferase inhibitors.
    Gelain A; Barlocco D; Kwon BM; Jeong TS; Im KR; Legnani L; Toma L
    J Med Chem; 2008 Mar; 51(5):1474-7. PubMed ID: 18284184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and biological evaluation of benzo[a]carbazole-based small molecule agonists of the thrombopoietin (Tpo) receptor.
    Alper PB; Marsilje TH; Mutnick D; Lu W; Chatterjee A; Roberts MJ; He Y; Karanewsky DS; Chow D; Lao J; Gerken A; Tuntland T; Liu B; Chang J; Gordon P; Seidel HM; Tian SS
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5255-8. PubMed ID: 18778936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a selective and potent radioactive ligand for histamine H(3) receptors: A compound potentially useful for receptor occupancy studies.
    Mitobe Y; Ito S; Mizutani T; Nagase T; Sato N; Tokita S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4075-8. PubMed ID: 19553110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and SAR of 1,4,5,6-tetrahydropyridazines as potent cannabinoid CB1 receptor antagonists.
    Lange JH; den Hartog AP; van der Neut MA; van Vliet BJ; Kruse CG
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5675-8. PubMed ID: 19699640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.
    McKinnell RM; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum A; Humphrey PP; Long DD; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    J Med Chem; 2009 Sep; 52(17):5330-43. PubMed ID: 19663444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
    Vachal P; Fletcher JM; Fong TM; Huang CC; Lao J; Xiao JC; Shen CP; Strack AM; Shearman L; Stribling S; Chen RZ; Frassetto A; Tong X; Wang J; Ball RG; Tsou NN; Hickey GJ; Thompson DF; Faidley TD; Nicolich S; Achanfuo-Yeboah J; Hora DF; Hale JJ; Hagmann WK
    J Med Chem; 2009 Apr; 52(8):2550-8. PubMed ID: 19320488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening technologies for G protein-coupled receptors: from HTS to uHTS.
    De los Frailes M; Diez E
    Methods Mol Biol; 2009; 552():15-37. PubMed ID: 19513639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.